Sign in

William Beaubien-Souligny

@wbeaubien.bsky.social
45 followers 22 following 2 posts

Canadian Nephrologist and clinical researcher at the CHUM. #AKI #POCUS #cardiorenal #VExUS

PostsRepliesMedia
William Beaubien-Souligny @wbeaubien.bsky.social · 19/01/2026
Attending #AKICRRT2026 this year? Please consider registering to to #POCUS course where Dr Deschamps and our outstanding faculty will share insights about our to use POCUS at the bedside of AKI patients.
000
Reposted by William Beaubien-Souligny
ravindram.bsky.social @ravindram.bsky.social · 12/01/2026
Highlights include CME credits, hands-on workshops, and exclusive symposia on AKI, POCUS, CRRT, and pediatric nephrology. Save now. Learn more. See you in San Diego! 🌴 👉 Register before Jan 19: [conference link] #AKICRRT2026 #CriticalCare #Nephrology #CME #Conference
011
Reposted by William Beaubien-Souligny
Canadian Society of Nephrology @csnscn.bsky.social · 20/10/2025
The next #CSNAGM with CKD-N will be in Quebec City May 6-8 2026 With the precourse on May 5-6 More details coming soon
The next CSN AGM
022
Reposted by William Beaubien-Souligny
American Journal of Hypertension @amjhypertension.bsky.social · 09/09/2025
As the 🍎⌚️introduces ‘hypertension monitoring’ - this statement from @hypertensioncanada.bsky.social is a useful read on the topic of cuffless blood pressure measurement pubmed.ncbi.nlm.nih.gov/39661401/
pubmed.ncbi.nlm.nih.gov
Hypertension Canada Statement on the Use of Cuffless Blood Pressure Monitoring Devices in Clinical Practice - PubMed
Cuffless BP devices are a developing technology designed to track BP in most daily life activities. However, many steps remain before they should be used in clinical practice.
065
Reposted by William Beaubien-Souligny
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 15/08/2025
Spironolactone does not work for dialysis ACHIEVE published in @thelancet.com @lastwalsh.bsky.social and colleagues www.thelancet.com/journals/lan... Coming soon to a #NephJC near you
thelancet.com
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial
Among patients receiving maintenance dialysis, spironolactone 25 mg daily orally did not reduce the composite outcome of cardiovascular mortality and hospitalisation due to heart failure compared with...
53119
William Beaubien-Souligny @wbeaubien.bsky.social · 16/06/2025
We are searching for physicians who use #VExUS #POCUS regularly. Become a collaborator for this important research project that aims to understand how venous Doppler influence medical decision making.
vexusresearch.org
VExUS-users study
Understanding how venous Doppler impacts clinical decisions
145